Andrew Chase

9.1k total citations · 1 hit paper
103 papers, 5.9k citations indexed

About

Andrew Chase is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Andrew Chase has authored 103 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Hematology, 56 papers in Genetics and 37 papers in Rheumatology. Recurrent topics in Andrew Chase's work include Chronic Myeloid Leukemia Treatments (65 papers), Acute Myeloid Leukemia Research (37 papers) and Eosinophilic Disorders and Syndromes (37 papers). Andrew Chase is often cited by papers focused on Chronic Myeloid Leukemia Treatments (65 papers), Acute Myeloid Leukemia Research (37 papers) and Eosinophilic Disorders and Syndromes (37 papers). Andrew Chase collaborates with scholars based in United Kingdom, Germany and United States. Andrew Chase's co-authors include Nicholas C.P. Cross, Francis Grand, John M. Goldman, Andreas Reiter, David Oscier, Amy V. Jones, Katerina Zoi, J Bungey, Thomas Ernst and Claire Hidalgo-Curtis and has published in prestigious journals such as New England Journal of Medicine, Cell and Nature Genetics.

In The Last Decade

Andrew Chase

99 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

2010 807 citations Thomas Ernst, Andrew Chase et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Chase United Kingdom	39	3.5k	2.7k	2.5k	1.5k	619	103	5.9k
E. Joanna Baxter United Kingdom	20	3.3k 1.0×	2.4k 0.9×	4.1k 1.6×	2.2k 1.4×	726 1.2×	41	5.6k
Philip Beer United Kingdom	32	2.3k 0.6×	2.4k 0.9×	2.7k 1.1×	955 0.6×	722 1.2×	87	4.6k
François Delhommeau France	26	3.0k 0.9×	2.7k 1.0×	3.7k 1.5×	1.4k 0.9×	657 1.1×	81	5.2k
Hana Raslová France	29	3.1k 0.9×	2.4k 0.9×	3.2k 1.3×	1.1k 0.7×	785 1.3×	75	5.2k
Anthony J. Bench United Kingdom	26	3.6k 1.0×	3.3k 1.2×	4.9k 2.0×	2.0k 1.3×	779 1.3×	48	6.2k
Philipp Erben Germany	32	2.0k 0.6×	830 0.3×	1.8k 0.7×	1.5k 1.0×	640 1.0×	161	3.8k
Rebecca F. McClure United States	31	2.4k 0.7×	2.0k 0.7×	2.9k 1.2×	1.4k 0.9×	515 0.8×	64	4.5k
CR Bartram Germany	28	2.4k 0.7×	1.3k 0.5×	1.3k 0.5×	419 0.3×	714 1.2×	68	3.8k
Catherine Lacout France	22	2.6k 0.7×	2.2k 0.8×	3.3k 1.3×	1.3k 0.8×	740 1.2×	47	4.3k
Ryan A. Knudson United States	28	2.3k 0.6×	1.4k 0.5×	2.0k 0.8×	535 0.3×	372 0.6×	89	3.4k

Countries citing papers authored by Andrew Chase

Since Specialization

Citations

This map shows the geographic impact of Andrew Chase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Chase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Chase more than expected).

Fields of papers citing papers by Andrew Chase

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Chase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Chase. The network helps show where Andrew Chase may publish in the future.

Co-authorship network of co-authors of Andrew Chase

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Chase. A scholar is included among the top collaborators of Andrew Chase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Chase. Andrew Chase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tapper, William, Joannah Score, Andrew Chase, et al.. (2025). Genome-wide analysis defines genetic determinants of MPN subtypes and identifies a sex-specific association at CDH22 / CD40. Blood. 146(26). 3228–3233.

Carreño‐Tarragona, Gonzalo, María Tiana, Alejandra Leivas, et al.. (2025). The JAK2 46/1 haplotype influences PD-L1 expression. Blood. 145(19). 2196–2201.

Chase, Andrew, et al.. (2023). Changes in Agricultural Soil Organic Carbon in Northern New England: 1995 to 2021. SSRN Electronic Journal. 1 indexed citations

Lam, Wayne, Nora Shannon, Karen Knapp, et al.. (2020). Pathogenic variants causing ABL1 malformation syndrome cluster in a myristoyl-binding pocket and increase tyrosine kinase activity. European Journal of Human Genetics. 29(4). 593–603. 10 indexed citations

Chase, Andrew, Catherine Bryant, J Score, et al.. (2012). Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements. Haematologica. 98(3). 404–408. 30 indexed citations

Ernst, Thomas, Andrew Chase, Katerina Zoi, et al.. (2010). Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms. Haematologica. 95(9). 1473–1480. 46 indexed citations

Kreil, Sebastian, Katherine Waghorn, Thomas Ernst, et al.. (2010). A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon . Haematologica. 95(1). 148–152. 25 indexed citations

Chase, Andrew, Thomas Ernst, Andreas Fiebig, et al.. (2009). TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals. Haematologica. 95(1). 20–26. 56 indexed citations

Hidalgo-Curtis, Claire, Jane F. Apperley, Michael Jeng, et al.. (2009). Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib‐responsive myeloproliferative neoplasms. British Journal of Haematology. 148(2). 268–273. 6 indexed citations

10.

Grand, Francis, Sameena Iqbal, Lingyan Zhang, et al.. (2007). A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy. Experimental Hematology. 35(11). 1723–1727. 39 indexed citations

11.

Chase, Andrew, et al.. (2003). Testing in-vitro for imatinib sensitivity in BCR-ABL negative myeloproliferative disorders. Blood. 102(11). 658–70. 1 indexed citations

12.

Hasserjian, Robert P., Sally Parker, Andrew Chase, et al.. (2002). STI571 (Imatinib Mesylate) Reduces Bone Marrow Cellularity and Normalizes Morphologic Features Irrespective of Cytogenetic Response. American Journal of Clinical Pathology. 117(3). 360–367. 52 indexed citations

13.

Kaeda, Jaspal, Andrew Chase, & John M. Goldman. (2002). Cytogenetic and Molecular Monitoring of Residual Disease in Chronic Myeloid Leukaemia. Acta Haematologica. 107(2). 64–75. 46 indexed citations

14.

Sohal, Jastinder, Andrew Chase, J M Goldman, & Nicholas C.P. Cross. (1999). Assignment<footref rid="foot01"><sup>1</sup></footref> of ZNF262 to human chromosome band 1p34→p32 by in situ hybridization. Cytogenetic and Genome Research. 85(3-4). 306–307. 7 indexed citations

15.

Macdonald, Donald, et al.. (1999). A case of myelofibrosis with a t(4;13)(q25;q12): evidence for involvement of a second 13q12 locus in chronic myeloproliferative disorders. British Journal of Haematology. 105(3). 771–774. 6 indexed citations

16.

Macdonald, Donald, et al.. (1999). Cloning and Characterization ofRNF6,a Novel RING Finger Gene Mapping to 13q12. Genomics. 58(1). 94–97. 21 indexed citations

17.

Grand, Francis, Andrew Chase, Sameena Iqbal, et al.. (1998). A two-colorBCR–ABL probe that greatly reduces the false positive and false negative rates for fluorescence in situ hybridization in chronic myeloid leukemia. Genes Chromosomes and Cancer. 23(2). 109–115. 22 indexed citations

18.

Chase, Andrew, Kim Orchard, A. E. Watmore, et al.. (1998). Two cases of inv(8)(p11q13) in AML with erythrophagocytosis: a new cytogenetic variant. British Journal of Haematology. 100(3). 561–563. 29 indexed citations

19.

Savage, David G., Richard Szydlo, Andrew Chase, Jane F. Apperley, & J M Goldman. (1997). Bone marrow transplantation for chronic myeloid leukaemia: the effects of differing criteria for defining chronic phase on probabilities of survival and relapse. British Journal of Haematology. 99(1). 30–35. 43 indexed citations

20.

Grigg, Jonathan, Shmuel Arnon, Andrew Chase, & Michael E. Silverman. (1993). Inflammatory cells in the lungs of premature infants on the first day of life: perinatal risk factors and origin of cells.. Archives of Disease in Childhood. 69(1 Spec No). 40–43. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact